1	Effects	Effect	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	1	1	_	_	_	_	_	_	_
4	alpha	alpha	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	25-dihydroxyvitamin	25-dihydroxyvitamin	_	_	_	_	_	_	_
7	D3	d3	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	chronic	chronic	_	_	_	_	_	_	_
12	myelogenous	myelogenous	_	_	_	_	_	_	_
13	leukemia	leukemia	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	line	line	_	_	_	_	_	_	_
16	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	1	1	_	_	_	_	_	_	_
5	alpha	alpha	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	25-dihydroxyvitamin	25-dihydroxyvitamin	_	_	_	_	_	_	_
8	D3	D3	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	VD3	VD3	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	proliferation	proliferation	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	differentiation	differentiation	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	macromolecular	macromolecular	_	_	_	_	_	_	_
19	synthesis	synthesis	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	new	new	_	_	_	_	_	_	_
23	Philadelphia	Philadelphia	_	_	_	_	_	_	_
24	chromosome-positive	chromosome-positive	_	_	_	_	_	_	_
25	chronic	chronic	_	_	_	_	_	_	_
26	myelogenous	myelogenous	_	_	_	_	_	_	_
27	leukemia	leukemia	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	line	line	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	were	be	_	_	_	_	_	_	_
34	investigated	investigate	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	[	[	_	_	_	_	_	_	_
4	3H]VD3	3H]VD3	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	saturable	saturable	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	approximately	approximately	_	_	_	_	_	_	_
10	2000-3000	2000-3000	_	_	_	_	_	_	_
11	sites/cell	sites/cell	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	half-maximal	half-maximal	_	_	_	_	_	_	_
15	binding	binding	_	_	_	_	_	_	_
16	occurring	occur	_	_	_	_	_	_	_
17	at	at	_	_	_	_	_	_	_
18	0.21-0.33	0.21-0.33	_	_	_	_	_	_	_
19	nM	nm	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	VD3	VD3	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	24R-hydroxylase	24R-hydroxylase	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	marker	marker	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	vitamin	vitamin	_	_	_	_	_	_	_
15	D3	d3	_	_	_	_	_	_	_
16	responsiveness	responsiveness	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	many	many	_	_	_	_	_	_	_
19	tissues	tissue	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Exposure	exposure	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	VD3	VD3	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	inhibited	inhibit	_	_	_	_	_	_	_
9	proliferation	proliferation	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	DNA	dna	_	_	_	_	_	_	_
12	synthesis	synthesis	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	50	50	_	_	_	_	_	_	_
16	%	%	_	_	_	_	_	_	_
17	effective	effective	_	_	_	_	_	_	_
18	dose	dose	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	3.5-10	3.5-10	_	_	_	_	_	_	_
21	nM	nm	_	_	_	_	_	_	_
22	within	within	_	_	_	_	_	_	_
23	72	72	_	_	_	_	_	_	_
24	h	h	_	_	_	_	_	_	_
25	;	;	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	addition	addition	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	protein	protein	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	RNA	RNA	_	_	_	_	_	_	_
32	synthesis	synthesis	_	_	_	_	_	_	_
33	were	be	_	_	_	_	_	_	_
34	inhibited	inhibit	_	_	_	_	_	_	_
35	by	by	_	_	_	_	_	_	_
36	VD3	vd3	_	_	_	_	_	_	_
37	treatment	treatment	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Exposure	exposure	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	5	5	_	_	_	_	_	_	_
7	nM	nm	_	_	_	_	_	_	_
8	VD3	vd3	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	72	72	_	_	_	_	_	_	_
11	h	h	_	_	_	_	_	_	_
12	caused	cause	_	_	_	_	_	_	_
13	50	50	_	_	_	_	_	_	_
14	%	%	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	differentiate	differentiate	_	_	_	_	_	_	_
20	into	into	_	_	_	_	_	_	_
21	macrophage/monocyte	macrophage/monocyte	_	_	_	_	_	_	_
22	type	type	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	as	as	_	_	_	_	_	_	_
25	judged	judge	_	_	_	_	_	_	_
26	by	by	_	_	_	_	_	_	_
27	nitroblue	nitroblue	_	_	_	_	_	_	_
28	tetrazolium	tetrazolium	_	_	_	_	_	_	_
29	staining	staining	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	adherence	adherence	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	plastic	plastic	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Progressive	progressive	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	surface	surface	_	_	_	_	_	_	_
6	maturation-specific	maturation-specific	_	_	_	_	_	_	_
7	antigens	antigen	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	monocyte/macrophage	monocyte/macrophage	_	_	_	_	_	_	_
11	lineage	lineage	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	treatment	treatment	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	VD3	vd3	_	_	_	_	_	_	_
21	for	for	_	_	_	_	_	_	_
22	24	24	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	72	72	_	_	_	_	_	_	_
25	h	h	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	doses	dose	_	_	_	_	_	_	_
28	that	that	_	_	_	_	_	_	_
29	inhibited	inhibit	_	_	_	_	_	_	_
30	cellular	cellular	_	_	_	_	_	_	_
31	proliferation.	proliferation.	_	_	_	_	_	_	_
32	c-myc	c-myc	_	_	_	_	_	_	_
33	RNA	RNA	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	which	which	_	_	_	_	_	_	_
36	is	be	_	_	_	_	_	_	_
37	constitutively	constitutively	_	_	_	_	_	_	_
38	expressed	express	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	RWLeu-4	rwleu-4	_	_	_	_	_	_	_
41	cells	cell	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	increased	increase	_	_	_	_	_	_	_
44	after	after	_	_	_	_	_	_	_
45	0.5	0.5	_	_	_	_	_	_	_
46	h	h	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	treatment	treatment	_	_	_	_	_	_	_
49	with	with	_	_	_	_	_	_	_
50	50	50	_	_	_	_	_	_	_
51	nM	nm	_	_	_	_	_	_	_
52	VD3	vd3	_	_	_	_	_	_	_
53	and	and	_	_	_	_	_	_	_
54	then	then	_	_	_	_	_	_	_
55	rapidly	rapidly	_	_	_	_	_	_	_
56	decreased	decrease	_	_	_	_	_	_	_
57	to	to	_	_	_	_	_	_	_
58	barely	barely	_	_	_	_	_	_	_
59	detectable	detectable	_	_	_	_	_	_	_
60	levels	level	_	_	_	_	_	_	_
61	after	after	_	_	_	_	_	_	_
62	4	4	_	_	_	_	_	_	_
63	h	h	_	_	_	_	_	_	_
64	of	of	_	_	_	_	_	_	_
65	treatment	treatment	_	_	_	_	_	_	_
66	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	vitro	vitro	_	_	_	_	_	_	_
6	tyrosine	tyrosine	_	_	_	_	_	_	_
7	kinase	kinase	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	p210bcr-abl	p210bcr-abl	_	_	_	_	_	_	_
13	oncogene	oncogene	_	_	_	_	_	_	_
14	product	product	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	decreased	decrease	_	_	_	_	_	_	_
17	approximately	approximately	_	_	_	_	_	_	_
18	50	50	_	_	_	_	_	_	_
19	%	%	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	VD3	vd3	_	_	_	_	_	_	_
22	treatment	treatment	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	presence	presence	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	functional	functional	_	_	_	_	_	_	_
8	receptor-effector	receptor-effector	_	_	_	_	_	_	_
9	system	system	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	VD3	vd3	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	multiple	multiple	_	_	_	_	_	_	_
14	biological	biological	_	_	_	_	_	_	_
15	responses	response	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	hormone	hormone	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	these	these	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	provide	provide	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	unique	unique	_	_	_	_	_	_	_
25	model	model	_	_	_	_	_	_	_
26	system	system	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	which	which	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	probe	probe	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	specific	specific	_	_	_	_	_	_	_
33	effects	effect	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	VD3	vd3	_	_	_	_	_	_	_
36	on	on	_	_	_	_	_	_	_
37	cell	cell	_	_	_	_	_	_	_
38	growth	growth	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	differentiation	differentiation	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	chronic	chronic	_	_	_	_	_	_	_
43	myelogenous	myelogenous	_	_	_	_	_	_	_
44	leukemia	leukemia	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

